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556a Tuesday, February 28, 2012phosphorylation at Ser150, although global TnI phosphorylation was un-
changed. There exists a sexually dimorphic pattern of AMPK expression and
activity, suggesting sexual dimorphic regulation of cellular metabolism and
energetics. Increased calcium sensitivity may provide sufficient contractile sup-
port in R403Q females maintaining a compensated state of cardiac function,
a characteristic not exhibited in males.
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According to the Frank-Starling relationship, greater ventricular volume in-
creases ventricular output. The Frank-Starling relationship is based partly on
the length-tension relationship in cardiac myocytes. Recently, we identified
two populations of length-tension relationships in mammalian cardiac myo-
cytes, which was dependent on PKA-induced myofibrillar phosphorylation.
We also observed a relationship between cardiac troponin I (cTnI) phosphory-
lation and steepness of ventricular function curves in rat working hearts. Thus,
we tested the hypothesis that phosphorylation of cTnI is sufficient and/or nec-
essary to control the length dependence of force generation. Our approach took
advantage of the fact that troponin can be readily exchanged in permeabilized
striated muscle cell preparations. We first used permeabilized rat slow-twitch
skeletal muscle fibers, which exhibit shallow length-tension relationships that
are unaltered by PKA. A sarcomere length-tension relationship was measured
during submaximal Ca2þ activation then the fiber was incubated in a troponin
(Tn) exchange solution, which replaced nearly all the endogenous slow Tn with
cTn. After cTn incorporation the length-tension relationship remained shallow
as predicted since the purified cTnI lacks phosphate incorporation. Next, the fi-
ber was incubated in PKA and a final sarcomere length-tension relationship
measured. Contrary to our prediction, the length-tension relationship remained
shallow after PKA phosphorylation of exogeneous cTnI. We next tested
whether cTnI phosphorylation is necessary to steepen length-tension relation-
ships in a cardiac myofibrillar background. For these experiments, we ex-
changed unphosphorylated cTn into a PKA treated myocyte that displayed
a steep length-tension relationship. In this case cTn exchange shifted the
length-tension relationship from a steep to a shallow relation. These results in-
dicate that cTnI phosphorylation is not sufficient to alter length dependence of
force generation in slow-twitch skeletal muscle fibers but appears necessary to
convert the length-tension relationship from steep to shallow in cardiac
myocytes.
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We have an engineered FRET assay in cardiac troponin (cTn) that monitors the
main structural change in troponin during activation. We performed single pair
FRET (spFRET) measurements using pulsed interleaved excitation (PIE) in the
following freely diffusing assemblies: cTn, quaternary troponin-tropomyosin
complex (TnTm), regulated thin filament (TnTnA7), and regulated thin fila-
ment in the presence of rigor cross-bridges (TnTmA7S1). 2D FRET histogram
analysis of the data reveals the populations of activated and inactivated Tn. We
report these populations under Ca2þ -free (apo) and Ca2þ -saturated (holo)
conditions.
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We have an engineered FRET assay in cardiac troponin that monitors the main
structural change in troponin during activation. We report the results of differ-
ent methods for exchanging the construct into myofibrils isolated from adult
mouse ventricular cardiomyocytes. Fluorescence lifetime imaging (FLIM) re-
vealed heterogeneous activation of troponin between the A- and I-bands in
rigor myofibrils. This suggests that strongly-bound cross bridges play a role
in the activation of the cardiac myofilament. These measurements are a precur-
sor to single pair FRET measurements of the activation of troponin within the
cardiac myofilament.2826-Pos Board B596
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We have examined various methods for introducing an engineered fluorescent
dye molecule-labeled troponin into cultured primary mouse ventricular
myocytes. The troponin complex is transported through the cell membrane
using a cell-penetrating peptide and allowed to exchange with endogenous
troponin within the myofilament. Exchange has been monitored using scanning
confocal imaging and by fluorescence lifetime imaging (FLIM). This work
may enable single pair FRET measurements of myocardial activation in
live cells.
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p21 activated kinase-1(Pak1) is a serine/threonine protein kinase functionally
linked to small and large GTPases. In the heart, Pak1 regulates activities of
ion channels and myofilament proteins through activation of phosphatase
PP2A. In mice deficient in Pak1 (Pak1-KO), ventricular hypertrophy and fibro-
sis develop in young adult (age 3-4 months). To test the hypothesis that mod-
ulation of Pak1 activity may control the progression of cardiac hypertrophy and
fibrosis, we used peptides, PRR-1, KI and Cdc42-switch I derived from Pak1
and its upstream activator Cdc42 to investigate their effects regulating activities
of angiotensin II in vivo. Angiotensin II and the peptides were infused in wt or
Pak1-KO mice through a mini-osmotic pump. Compared to those treated with
angiotensin II alone hearts from mice treated with angiotensin II plus peptides
demonstrated significantly reduced fibrosis and hypertrophy with reduced hy-
droxyproline. This inhibitory effect was absent in Pak1-KO mice. The peptide
also changes (inhibits) protein phosphorylation on signaling molecules, such as
Erk1 and SMAD3. Our studies indicate that the bioactive peptide can effi-
ciently inhibit ventricular fibrosis and hypertrophy by interacting with endog-
enous Pak1.
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In normal heart, troponin I (TnI) phosphorylation alters myofibrillar Ca2þ-sen-
sitivity and increases the speed of Ca2þ-dissociation (lusitropic effect). We
have discovered several cases in human heart muscle (DCM mutations,
HCM mutations, septal myectomy) where Ca2þ-sensitivity is independent of
TnI phosphorylation.
The ACTC E361G DCM mutation had no effect upon Ca2þ-sensitivity at all
when tested in thin filaments containing donor heart troponin. However if tro-
ponin was dephosphorylated, the wild-type actin containing thin filaments had
a higher Ca2þ-sensitivity than ACTC E361G containing thin filaments. Thus,
Ca2þ-sensitivity is uncoupled from TnI phosphorylation. This was also ob-
served with another 6 DCM mutations (TnT R141W, TnI K36Q, TnC
G159D and Tm E40K and E54K).
The ACTC E99KHCMmutation causes an increase in Ca2þ-sensitivity, but un-
coupling also occurs, as there is no difference in the Ca2þ-sensitivity of ACTC
E99K containing thin filaments with phosphorylated and dephosphorylated tro-
ponin. The uncoupling must be a direct effect of the mutation, which influences
TnI properties allosterically.
We have been studying myectomy samples as a source of human HCM tissue.
The Ca2þ-sensitivity of thin filaments with HOCM troponin was the same as
donor heart troponin even though the TnI phosphorylation levels were very dif-
ferent. This uncoupling is independent of the mutation causing HCM so one of
the troponin subunits is functionally abnormal. When HOCM troponin was ex-
changed with recombinant TnT there was a 1.9-fold higher Ca2þ-sensitivity as
was expected with the low level of phosphorylation. Therefore a change in TnT
is responsible for the observed disruption of the Ca2þ-sensitivity-phosphoryla-
tion relationship in human myectomy samples.
Thus, the ‘uncoupling’ phenomenon seems to be a widespread consequence of
cardiomyopathy and plays a key role in the pathogenesis of familial cardiomyo-
pathy.
